A Retrospective Study Of the Efficacy And Toxicity Of Capecitabine In Advanced Breast Cancer
Sarah Yousri Muhamad;
Abstract
Abstract
Maximum benefit is expected with careful selection of patients; young patients, those with good initial ECOG performance status, hormone receptor positive patients, chemotherapy-naïve patients, those with relatively low disease burden, and patients with no visceral sites of involvement.
Still, further larger multi-center studies are needed for proper characterization of our population, to identify prognostic factors and determinants of survival, and to maximize treatment strategies for our patients.
Maximum benefit is expected with careful selection of patients; young patients, those with good initial ECOG performance status, hormone receptor positive patients, chemotherapy-naïve patients, those with relatively low disease burden, and patients with no visceral sites of involvement.
Still, further larger multi-center studies are needed for proper characterization of our population, to identify prognostic factors and determinants of survival, and to maximize treatment strategies for our patients.
Other data
| Title | A Retrospective Study Of the Efficacy And Toxicity Of Capecitabine In Advanced Breast Cancer | Other Titles | دراسه استعاديه عن فاعلية و الأعراض الجانبيه لعقار الكابسيتابين فى أورام الثدي المتقدمة | Authors | Sarah Yousri Muhamad | Issue Date | 2017 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.